COSEL Launches New Compact 2”x3” Power Supply Series for Demanding Medical Applications

COSEL Co, Ltd today announced the expansion of its medical power offering with the addition of the new UMA series, the first two models being the 30W UMA30F and the 60W UMA60F. Both models feature a universal input range of 85 to 264VAC and comply with international safety standards. Designed for demanding medical applications, the UMA series is suitable for Body Floating (BF) applications and complies with 2MOPP (IN/OUT) and 1MOPP (OUT/FG) safety requirement. Based on a robust platform, the units’ design has been optimized to offer a very good price/performance ratio for medical applications requiring a high quality power solution. The UMA series is available in up to five output voltages of 5, 12, 15, 24, and 48VDC.

Medical applications are requiring robust and highly reliable power supplies that are able to operate around the world and comply with safety regulations. Based on many years of expertise, COSEL power designers developed an optimized flyback topology platform to offer an excellent price/performance ratio without compromising on quality and reliability. The UMA series can be operated within a universal Input range of 85 to 264VAC, and has a typical efficiency up to 91% at high line.

Currently four single output voltages are available as standard for the UMA30F: 5V/3A, 12V/2.5A, 24V/1.3A and 48V/0.65A, and five for the UMA60F: 5V/6A, 12V/4.5A, 15V/3.5A, 24V/2.5A and 48V/1.25A. Output is factory adjusted to a fixed value, but in applications where output voltage adjustment is required an option ‘Y’ with potentiometer is available.

The UMA series includes inrush current limiting circuitry, overcurrent, and overvoltage protection. Exhibiting versatility and robustness, the power supplies can be operated in an environmental temperature range of -20 to +70 degrees centigrade. Depending on the final equipment assembly style and cooling conditions, a derating may apply.

With its medical focus, the UMA series’ input to output isolation complies with 2MOPP, its input to Frame Ground (FG) complies with 1MOPP, and output to FG with 1MOPP. The units are approved in accordance with ANSI/AAMI ES60601-1 and EN60601-1 3rd Edition. In the case of Body Floating applications where patient leakage current must be less than 100 µA, with its 75 µA figure the UMA series is well below that limit and so eminently suitable for such applications.

The UMA series meets the following agency approvals: ANSI/AAMI ES60601-1, EN60601-1 3rd, C-UL (equivalent to CAN/CSA-C22.2 No.60601-1), UL62368-1, EN62368-1, C-UL (equivalent to CAN/CSA-C22.2 No.62368-1) and complies with EN60335-1.

To accommodate application specific requirements, three options are available including adjustable output voltage (Y), terminal block (T), and for applications requiring additional safety the UMA30F and UMA60F are available with reinforced isolation in conformance with the IEC class II (E).

The UMA30F measures 50.8 x 21.7 x 76.2mm [2.0 x 0.85 x 3.0 inches] (W x H x D) and weighs 80g max. The UMA60F is just 2.5mm taller (24.2mm) and weighs 120g max.

The UMA series has an excellent five-year warranty and conforms to the European RoHS and Low Voltage Directives.

The combination of small size, excellent cost/performance ratio, and high quality makes the UMA series an ideal power solution for demanding applications not only in the medical market but also for test and measurement, and industrial applications including household and similar electrical appliances.

SourceCOSEL

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.